BioStem Technologies, Inc. (BSEM) Financials
BSEM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 48.8 million | 21.2 million |
| March 31, 2026 | 55.1 million | 23.2 million |
| Dec. 31, 2025 | 50.0 million | 10.9 million |
| Sept. 30, 2025 | 62.4 million | 12.4 million |
BSEM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -5.6 million | 2.4 million |
| March 31, 2026 | -827295 | 1.6 million |
| Dec. 31, 2025 | 2.4 million | ? |
| Sept. 30, 2025 | -4.8 million | ? |
BSEM Net Income
No data available :(
BSEM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 7.0 million | 1355 | 1355 |
| March 31, 2026 | 13.7 million | - | 279704 |
| Dec. 31, 2025 | 29.5 million | 105262 | 331030 |
| Sept. 30, 2025 | 27.2 million | - | 387156 |
BSEM Shares Outstanding
BSEM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 56131 | 733616 | 11.8 million | 5.3 million |
| March 31, 2026 | 1794 | 1.1 million | 11.0 million | - |
| Dec. 31, 2025 | 436844 | 1.5 million | -79.1 million | - |
| Sept. 30, 2025 | 2.4 million | 2.0 million | 5.8 million | 1.3 million |
BSEM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 7.9 million | 3.1 million |
| March 31, 2026 | 6.1 million | 2.9 million |
| Dec. 31, 2025 | -84.8 million | 461454 |
| Sept. 30, 2025 | 10.5 million | 1.3 million |
BSEM
Price: $3.54
52 week price:
Earnings Per Share: 0.88 USD
P/E Ratio: 3.65
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 57.2 million